GLASGOW, Scotland – 20 June 2025 – Chemify, the deep-tech pioneer fusing chemistry, robotics, computation and AI to digitise molecule creation, today unveiled its first Chemifarm—a fully automated chemistry facility regarded as the world’s most advanced laboratory for molecular design and synthesis.

Situated in Glasgow’s Maryhill district, the 21,500-ft² site unites Chemify’s AI-driven molecular-design engine with industrial-scale robotic synthesis, compressing the journey from concept to compound and accelerating the discovery of small-molecule medicines and next-generation materials for partners tackling society’s toughest challenges.

At Chemifarm’s core is the Chemputation platform—a bespoke programming language, extensible robotics, and the world’s largest curated, and fastest growing, library of validated reactions—enabling the on-demand design, optimisation and scale-up of molecules once deemed unreachable. 

“The first Chemifarm is a watershed moment for molecular innovation,” said Lee Cronin, CEO and Founder of Chemify. “By combining automation, AI and scalable synthesis, we can now move from code to compound faster than ever, fueling breakthroughs in drug discovery, materials science and beyond.”

A 2022 spin-out from the University of Glasgow, Chemify grew from Professor Cronin’s research in digital chemistry. “Chemifarm’s launch exemplifies the transformative impact that emerges when academic excellence translates into industrial innovation. This is a hugely significant milestone - as a University, we are committed to working with our partners and funders to enable our cutting edge research to translate into successful spin-outs that scale-up and deliver impact on the regional economy creating jobs and strengthening our regional economic clusters,” noted Professor Sir Anton Muscatelli, Principal and Vice-Chancellor of the University.

The facility features dedicated production suites, R&D labs, engineering and fabrication zones and a secure cloud architecture capable of storing petabytes of high-resolution chemical data for AI-powered analysis. It will also prototype next-generation Chemifarm hardware destined for future global sites.

The £12 million project is supported through the Glasgow City Region Innovation Accelerator Programme, a UK Government-led initiative delivered by Innovate UK. Scottish Enterprise also provided a grant of £1.1M to Chemify for the project. Chemify’s new facility will create 60 new jobs and safeguard over 50 existing roles in Glasgow, Scotland.

Chemify already partners with major pharmaceutical, biotech and materials-science companies, offering confidential, on-demand access to bespoke molecules for early-stage research and development. The Chemifarm will be integral to these research and development efforts to develop innovative chemical compounds with specific properties, designing and making chemical compounds and small physical samples for testing throughout the research process.

Dean Cook, Director for Place and Global at Innovate UK, said: “A key objective of the Innovation Accelerator programme was to drive the technologies of tomorrow, so it’s fantastic to see Chemify launch the world’s first Chemputation facility. Their pioneering Chemifarm perfectly illustrates how place-based innovation support can deliver global impact by leveraging regional strengths. This facility further cements the UK’s reputation as a leader in advanced chemical and pharmaceutical industries.”

Chief Executive of Scottish Enterprise Adrian Gillespie said: “I am delighted to see Chemify’s expansion into this new state-of-the-art digital chemistry laboratory in Glasgow. This Chemifarm facility represents a significant milestone for the company, allowing them to drive innovation, create high-quality jobs and position Scotland at the forefront of the global healthtech market. Our backing of Chemify’s ambition underscores our commitment to doubling the number of innovative scaling companies in Scotland by 2030, by fostering a dynamic, sustainable, supportive economic environment for businesses to grow.”

Councillor Susan Aitken, Leader of Glasgow City Council and Chair of the Glasgow City Region Cabinet, said: “Chemify is a stand-out success story within our emerging innovation economy, one that's both enhancing Glasgow's reputation as an international centre of science and ingenuity while transforming the world of chemical production. The Chemifarm takes the company's presence in Glasgow to a new level, where it can continue to build on the City Region's support to create quality new jobs and leverage in further private investment as its success grows. The Innovation Accelerator programme which helped nurture Chemify is about real-world impacts. I'm delighted to see that impact on this city, with the next stage of Chemify's development taking shape in the heart of North Glasgow.”

About Chemify
Chemify is reimagining the discovery and synthesis of novel molecules for medicines and advanced materials by turning digital code into physical compounds through Chemputation—its fusion of robotics and AI. Headquartered in Glasgow, Scotland, the company was founded by Lee Cronin to digitalise chemistry at global scale for the benefit of humanity. Learn more at Chemify.io and follow @ChemifyX on X/Twitter. 

This contant was orignally distributed by Reportable. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Chemify Launches the World’s First Chemputation Facility Revolutionizing Molecular Design and Manufacture.